Found 66 matching trials
Research on the Psychological Status of Patients With HIV-1 Infection N/A The goal of this observational study is to investigate the neuropsychologic...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen PHASE2 The goal of this clinical study is to learn more about the effects of switc...
Show More Status
Active Not Recruiting
Location
Be Well Medical Center
Learn More & Join Trial
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments PHASE4 The goal of this clinical study is to provide continued access to the study...
Show More Learn More & Join Trial
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial) PHASE3 The purpose of this trial is to assess the non-inferior antiviral activity ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily PHASE3 The purpose of this trial is to assess the non-inferior antiviral activity ...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants PHASE3 The primary objective of this study is to evaluate the efficacy of switchin...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019 PHASE3 Dolutegravir is a potent integrase strand transfer inhibitor. Abacavir/dolu...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Efavirenz to Dolutegravir Switch in Patients With CNS Toxicity PHASE4 This is a phase IV, open label, multicentre trial that will be taking place...
Show More Location
Chelsea and Westminster Hospital
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults PHASE3 The primary objective of this study is to evaluate the efficacy of a fixed ...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
SSAT064: Pharmacokinetics of Abacavir/Lamivudine/Dolutegravir in HIV Patients of 60 Years and Over PHASE4 The purpose of this study is to identify the effects that ageing may have o...
Show More Location
St Stephen's Centre, Chelsea & Westminster Hospital
Learn More & Join Trial